Literature DB >> 15489344

Mycoplasma pneumoniae and its role as a human pathogen.

Ken B Waites1, Deborah F Talkington.   

Abstract

Mycoplasma pneumoniae is a unique bacterium that does not always receive the attention it merits considering the number of illnesses it causes and the degree of morbidity associated with it in both children and adults. Serious infections requiring hospitalization, while rare, occur in both adults and children and may involve multiple organ systems. The severity of disease appears to be related to the degree to which the host immune response reacts to the infection. Extrapulmonary complications involving all of the major organ systems can occur in association with M. pneumoniae infection as a result of direct invasion and/or autoimmune response. The extrapulmonary manifestations are sometimes of greater severity and clinical importance than the primary respiratory infection. Evidence for this organism's contributory role in chronic lung conditions such as asthma is accumulating. Effective management of M. pneumoniae infections can usually be achieved with macrolides, tetracyclines, or fluoroquinolones. As more is learned about the pathogenesis and immune response elicited by M. pneumoniae, improvement in methods for diagnosis and prevention of disease due to this organism may occur.

Entities:  

Mesh:

Year:  2004        PMID: 15489344      PMCID: PMC523564          DOI: 10.1128/CMR.17.4.697-728.2004

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  411 in total

1.  Substance P and its receptor neurokinin 1 expression in asthmatic airways.

Authors:  H W Chu; M Kraft; J E Krause; M D Rex; R J Martin
Journal:  J Allergy Clin Immunol       Date:  2000-10       Impact factor: 10.793

2.  Evidence that UGA is read as a tryptophan codon rather than as a stop codon by Mycoplasma pneumoniae, Mycoplasma genitalium, and Mycoplasma gallisepticum.

Authors:  J M Inamine; K C Ho; S Loechel; P C Hu
Journal:  J Bacteriol       Date:  1990-01       Impact factor: 3.490

3.  In vitro activity of BAY 12-8039, a new fluoroquinolone against mycoplasmas.

Authors:  C M Bébéar; H Renaudin; A Boudjadja; C Bébéar
Journal:  Antimicrob Agents Chemother       Date:  1998-03       Impact factor: 5.191

4.  Relationships between radiological pattern and cell-mediated immune response in Mycoplasma pneumoniae pneumonia.

Authors:  H Tanaka; H Koba; S Honma; F Sugaya; S Abe
Journal:  Eur Respir J       Date:  1996-04       Impact factor: 16.671

Review 5.  The cytadhesins of Mycoplasma pneumoniae and M. genitalium.

Authors:  J B Baseman
Journal:  Subcell Biochem       Date:  1993

6.  An outbreak of Mycoplasma pneumoniae infections in a hospital in Japan.

Authors:  S Kashiwagi; J Hayashi; H Nomura; W Kajiyama; H Ikematsu; T Shingu; K Hayashida; M Kaji
Journal:  Kurume Med J       Date:  1985

7.  Mycoplasma pneumoniae-associated nephritis in children.

Authors:  M H Saïd; M P Layani; S Colon; G Faraj; C Glastre; P Cochat
Journal:  Pediatr Nephrol       Date:  1999-01       Impact factor: 3.714

8.  Mycoplasma pneumoniae-induced activation and cytokine production in rodent mast cells.

Authors:  Kristen L Hoek; Gail H Cassell; Lynn B Duffy; T Prescott Atkinson
Journal:  J Allergy Clin Immunol       Date:  2002-03       Impact factor: 10.793

9.  Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children.

Authors:  J W Dorigo-Zetsma; S A Zaat; P M Wertheim-van Dillen; L Spanjaard; J Rijntjes; G van Waveren; J S Jensen; A F Angulo; J Dankert
Journal:  J Clin Microbiol       Date:  1999-01       Impact factor: 5.948

10.  Isolation of Mycoplasma pneumoniae from asthmatic patients.

Authors:  J C Gil; R L Cedillo; B G Mayagoitia; M D Paz
Journal:  Ann Allergy       Date:  1993-01
View more
  410 in total

1.  Loss of co-chaperone TopJ impacts adhesin P1 presentation and terminal organelle maturation in Mycoplasma pneumoniae.

Authors:  Jason M Cloward; Duncan C Krause
Journal:  Mol Microbiol       Date:  2011-06-23       Impact factor: 3.501

2.  Fatal outcomes in family transmission of Mycoplasma pneumoniae.

Authors:  T R Kannan; R D Hardy; J J Coalson; D C Cavuoti; J D Siegel; M Cagle; O Musatovova; C Herrera; J B Baseman
Journal:  Clin Infect Dis       Date:  2011-11-03       Impact factor: 9.079

3.  Multiclonal origin of macrolide-resistant Mycoplasma pneumoniae isolates as determined by multilocus variable-number tandem-repeat analysis.

Authors:  Yang Liu; Xinye Ye; Hong Zhang; Xiaogang Xu; Minggui Wang
Journal:  J Clin Microbiol       Date:  2012-05-30       Impact factor: 5.948

4.  Targeted chromosomal knockouts in Mycoplasma pneumoniae.

Authors:  Radha Krishnakumar; Nacyra Assad-Garcia; Gwynedd A Benders; Quang Phan; Michael G Montague; John I Glass
Journal:  Appl Environ Microbiol       Date:  2010-06-11       Impact factor: 4.792

5.  Synthesis and distribution of CARDS toxin during Mycoplasma pneumoniae infection in a murine model.

Authors:  T R Kannan; Jacqueline J Coalson; Marianna Cagle; Oxana Musatovova; R Doug Hardy; Joel B Baseman
Journal:  J Infect Dis       Date:  2011-09-28       Impact factor: 5.226

6.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

7.  Variation in colonization, ADP-ribosylating and vacuolating cytotoxin, and pulmonary disease severity among mycoplasma pneumoniae strains.

Authors:  Chonnamet Techasaensiri; Claudia Tagliabue; Marianna Cagle; Pooya Iranpour; Kathy Katz; Thirumalai R Kannan; Jacqueline J Coalson; Joel B Baseman; R Doug Hardy
Journal:  Am J Respir Crit Care Med       Date:  2010-05-27       Impact factor: 21.405

8.  Comparison of Molecular Characteristics of Mycoplasma pneumoniae Specimens Collected from the United States and China.

Authors:  Chao Yan; Hongmei Sun; Stella Lee; Rangaraj Selvarangan; Xuan Qin; Yi-Wei Tang; Ken B Waites; Xiaotian Zheng
Journal:  J Clin Microbiol       Date:  2015-12       Impact factor: 5.948

9.  In vitro subminimum inhibitory concentrations of macrolide antibiotics induce macrolide resistance in Mycoplasma pneumoniae.

Authors:  G Ou; Y Liu; Y Tang; X You; Y Zeng; J Xiao; L Chen; M Yu; M Wang; C Zhu
Journal:  Hippokratia       Date:  2015 Jan-Mar       Impact factor: 0.471

Review 10.  New insights into the pathogenesis and detection of Mycoplasma pneumoniae infections.

Authors:  Ken B Waites; Mitchell F Balish; T Prescott Atkinson
Journal:  Future Microbiol       Date:  2008-12       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.